Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02553642
Brief Title: Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

First Submitted : September 16, 2015
First Submitted that Met QC Criteria : September 16, 2015
First Posted : September 17, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 29, 2019
Last Update Posted : July 31, 2019